SOLENO THERAPEUTICS INC — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Yen Kristen | SEE REMARKS | Tax Withholding | 904 | $49.95 | $45,155 | 27,239 | Dec 15, 2025 |
| Manning Meredith | Chief Commercial Officer | Tax Withholding | 1,922 | $49.95 | $96,004 | 43,429 | Dec 15, 2025 |
| Mackaness James H | CHIEF FINANCIAL OFFICER | Tax Withholding | 2,013 | $49.95 | $100,549 | 103,163 | Dec 15, 2025 |
| Huang Michael F. | Sr. VP of Clinical Development | Tax Withholding | 812 | $49.95 | $40,559 | 36,005 | Dec 15, 2025 |
| Hirano Patricia C | SEE REMARKS | Tax Withholding | 904 | $49.95 | $45,155 | 12,302 | Dec 15, 2025 |
| Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | Gift | 100,000 | — | — | 469,456 | Dec 15, 2025 |
| Norrett Kevin | Chief Business Officer | Award / Grant | 14,286 | — | — | 14,286 | Nov 17, 2025 |
| Joshi Manher | Chief Development Officer | Award / Grant | 16,071 | — | — | 16,071 | Nov 10, 2025 |
| Hahn Mark W | — | Award / Grant | 10,046 | — | — | 10,046 | Oct 13, 2025 |
| Hirano Patricia C | SEE REMARKS | Sale | 3,830 | $82.76 | $316,971 | 13,206 | Jul 1, 2025 |
| Hirano Patricia C | SEE REMARKS | Option Exercise | 266 | $44.25 | $11,771 | 17,302 | Jun 24, 2025 |
| Volck Birgitte | — | Award / Grant | 3,991 | — | — | 17,536 | Jun 5, 2025 |
| Sinclair Andrew | — | Award / Grant | 3,991 | — | — | 10,491 | Jun 5, 2025 |
| Pauls Matthew | — | Award / Grant | 3,991 | — | — | 10,491 | Jun 5, 2025 |
| Harris William G | — | Award / Grant | 3,991 | — | — | 19,392 | Jun 5, 2025 |
| Bir Dawn Carter | — | Award / Grant | 3,991 | — | — | 16,991 | Jun 5, 2025 |
| Hirano Patricia C | SEE REMARKS | Sale | 3,782 | $70.11 | $265,156 | 27,036 | Apr 1, 2025 |
| Pauls Matthew | — | Sale | 5,937 | $71.55 | $424,792 | 6,500 | Mar 28, 2025 |
| Yen Kristen | SEE REMARKS | Sale | 5,239 | $67.70 | $354,680 | 73,116 | Mar 27, 2025 |
| Manning Meredith | Chief Commercial Officer | Sale | 37,000 | $67.04 | $2,480,480 | 45,351 | Mar 27, 2025 |
| Mackaness James H | CHIEF FINANCIAL OFFICER | Option Exercise | 20,000 | $30.75 | $615,000 | 125,176 | Mar 27, 2025 |
| Huang Michael F. | Sr. VP of Clinical Development | Sale | 371 | $65.97 | $24,475 | 41,029 | Mar 27, 2025 |
| Hirano Patricia C | SEE REMARKS | Sale | 1,418 | $65.97 | $93,545 | 110,884 | Mar 27, 2025 |
| Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | Sale | 55,234 | $68.79 | $3,799,547 | 617,861 | Mar 27, 2025 |
| Vivo Opportunity Fund Holdings, L.P. | — | Sale | 333,557 | $70.60 | $23,549,124 | 4,458,294 | Mar 27, 2025 |
| Yen Kristen | SEE REMARKS | Award / Grant | 6,400 | — | — | 83,005 | Jan 21, 2025 |
| Manning Meredith | Chief Commercial Officer | Award / Grant | 13,600 | — | — | 53,600 | Jan 21, 2025 |
| Mackaness James H | CHIEF FINANCIAL OFFICER | Award / Grant | 14,500 | — | — | 125,798 | Jan 21, 2025 |
| Huang Michael F. | Sr. VP of Clinical Development | Award / Grant | 6,400 | — | — | 41,400 | Jan 21, 2025 |
| Hirano Patricia C | SEE REMARKS | Award / Grant | 6,400 | — | — | 112,302 | Jan 21, 2025 |
| Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | Award / Grant | 53,900 | — | — | 752,362 | Jan 21, 2025 |
| Yen Kristen | SEE REMARKS | Sale | 198 | $45.92 | $9,092 | 78,945 | Jan 2, 2025 |
| Mackaness James H | CHIEF FINANCIAL OFFICER | Sale | 3,762 | $45.37 | $170,682 | 115,410 | Jan 2, 2025 |
| Hirano Patricia C | SEE REMARKS | Sale | 1,459 | $46.18 | $67,377 | 105,902 | Jan 2, 2025 |
| Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | Sale | 10,077 | $45.37 | $457,193 | 709,476 | Jan 2, 2025 |
| Yen Kristen | SEE REMARKS | Sale | 319 | $50.25 | $16,030 | 81,465 | Oct 1, 2024 |
| Mackaness James H | CHIEF FINANCIAL OFFICER | Sale | 7,248 | $49.34 | $357,616 | 120,001 | Oct 1, 2024 |
| Hirano Patricia C | SEE REMARKS | Sale | 2,789 | $49.34 | $137,609 | 109,251 | Oct 1, 2024 |
| Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | Sale | 19,413 | $49.34 | $957,837 | 721,773 | Oct 1, 2024 |
| Mackaness James H | CHIEF FINANCIAL OFFICER | Sale | 3,100 | $48.03 | $148,893 | 134,119 | Aug 29, 2024 |
| Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | Sale | 47,551 | $47.16 | $2,242,505 | 752,026 | Aug 29, 2024 |
| Yen Kristen | SEE REMARKS | Sale | 2,453 | $48.03 | $117,818 | 90,008 | Aug 28, 2024 |
| Hirano Patricia C | SEE REMARKS | Sale | 2,453 | $48.03 | $117,818 | 117,475 | Aug 28, 2024 |
| Vivo Opportunity, LLC | — | Sale | 425,000 | $47.35 | $20,123,750 | 6,391,851 | Aug 27, 2024 |
| Bir Dawn Carter | — | Award / Grant | 13,000 | — | — | 13,000 | Aug 15, 2024 |
| Yen Kristen | SEE REMARKS | Sale | 2,826 | $45.48 | $128,526 | 103,426 | Aug 6, 2024 |
| Mackaness James H | CHIEF FINANCIAL OFFICER | Sale | 3,858 | $45.48 | $175,462 | 151,905 | Aug 6, 2024 |
| Hirano Patricia C | SEE REMARKS | Sale | 2,834 | $45.48 | $128,890 | 130,920 | Aug 6, 2024 |
| Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | Sale | 6,789 | $43.64 | $296,272 | 918,532 | Aug 6, 2024 |
| Manning Meredith | Chief Commercial Officer | Award / Grant | 40,000 | — | — | 40,000 | Jul 17, 2024 |